Retatrutide Shows 28% Weight Loss in Phase 3 Trial
-
By
-
Kathryn Wighton
-
May 21, 2026
-
2 min
By
Kathryn Wighton
May 21, 2026
A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.
October 26, 2026
Investigators identify insulin resistance and obesity as possible contributors to neurologic changes.
October 21, 2026
National survey data show a greater mental health symptom burden among adults with type 1 diabetes vs. those with type 2 diabetes or no diabetes.
October 19, 2026